Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population

Kidney Int Suppl. 2003 Jun:(85):S111-4. doi: 10.1046/j.1523-1755.63.s85.26.x.

Abstract

Background: Cardiovascular disease is the main cause of morbidity and mortality among hemodialysis patients. Chronic renal failure influences a number of factors that cause accelerated atherogenesis, with calcium, phosphorus, and PTH playing key roles. Several studies have demonstrated the influence of these factors on all-cause and cardiovascular mortality in the American hemodialysis population. In the present study we evaluated the variables that influence long-term cardiovascular mortality in a European hemodialysis population.

Methods: One hundred and forty-three hemodialysis patients were followed for six years. Several Cox models were used to study the influence of demographic and biochemical data, and comorbid conditions in cardiovascular survival, with a particular interest in mineral metabolism.

Results: There was an increased risk of cardiovascular death in patients with serum P>6.5 mg/dL (risk ratio [RR], 2.5), PTH>50 pmol/L (RR, 3.9), Ca x P>52 (RR, 2.8), BB or Bb genotype (RR, 3.8), and in diabetics.

Conclusion: There is a stronger influence of mineral metabolism on cardiovascular death among European patients when compared to the American population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / mortality*
  • Europe / epidemiology
  • Female
  • Follow-Up Studies
  • Genotype
  • Humans
  • Kidney Failure, Chronic / genetics
  • Kidney Failure, Chronic / mortality*
  • Male
  • Middle Aged
  • Minerals / metabolism*
  • Proportional Hazards Models
  • Prospective Studies
  • Receptors, Calcitriol / genetics
  • Renal Dialysis / mortality*
  • Risk Factors

Substances

  • Biomarkers
  • Minerals
  • Receptors, Calcitriol